{
    "2020-07-02": [
        [
            {
                "time": "",
                "original_text": "医药中期策略：迎接后疫情时代 医药优先看好“5+X”",
                "features": {
                    "keywords": [
                        "医药",
                        "中期策略",
                        "后疫情时代",
                        "5+X"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业月报：医药6月流动性上升 步入业绩兑现期",
                "features": {
                    "keywords": [
                        "医药生物",
                        "月报",
                        "6月",
                        "流动性上升",
                        "业绩兑现期"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "生物疫苗板块午后持续下滑，长春高新、艾德生物、康泰生物、智飞生物领跌",
                "features": {
                    "keywords": [
                        "生物疫苗",
                        "午后",
                        "下滑",
                        "长春高新",
                        "艾德生物",
                        "康泰生物",
                        "智飞生物"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "29只沪深渝股上半年翻红前三强涨幅皆超100%",
                "features": {
                    "keywords": [
                        "沪深渝股",
                        "上半年",
                        "翻红",
                        "涨幅",
                        "100%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}